Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
Nordström
A L
AL
Nyberg
S
S
Olsson
H
H
Farde
L
L
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001569:Benzodiazepines; D002250:Carbon Radioisotopes; D003024:Clozapine / Q000493:pharmacokinetics / Q000627:therapeutic use; D003342:Corpus Striatum / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism*; D018492:Dopamine Antagonists; D005260:Female; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000453:epidemiology; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D020891:Raclopride; D011869:Radioligand Assay / Q000379:methods; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism*; D012457:Salicylamides; D012559:Schizophrenia / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D002250:Carbon Radioisotopes; D018492:Dopamine Antagonists; D017448:Receptors, Dopamine D2; D012457:Salicylamides; D001569:Benzodiazepines; D010890:Pirenzepine; D020891:Raclopride; D003024:Clozapine; D000077152:Olanzapine